A Novel In Vitro Multiple-Stress Dormancy Model for Mycobacterium tuberculosis Generates a Lipid-Loaded, Drug-Tolerant, Dormant Pathogen
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Mycobacterium tuberculosis (Mtb) becomes dormant and phenotypically drug resistant when it encounters multiple stresses within the host. Inability of currently available drugs to kill latent Mtb is a major impediment to curing and possibly eradicating tuberculosis (TB). Most in vitro dormancy models, using single stress factors, fail to generate a truly dormant Mtb population. An in vitro model that generates truly dormant Mtb cells is needed to elucidate the metabolic requirements that allow Mtb to successfully go through dormancy, identify new drug targets, and to screen drug candidates to discover novel drugs that can kill dormant pathogen. METHODOLOGY/PRINCIPAL FINDINGS: We developed a novel in vitro multiple-stress dormancy model for Mtb by applying combined stresses of low oxygen (5%), high CO(2) (10%), low nutrient (10% Dubos medium) and acidic pH (5.0), conditions Mtb is thought to encounter in the host. Under this condition, Mtb stopped replicating, lost acid-fastness, accumulated triacylglycerol (TG) and wax ester (WE), and concomitantly acquired phenotypic antibiotic-resistance. Putative neutral lipid biosynthetic genes were up-regulated. These genes may serve as potential targets for new antilatency drugs. The triacylglycerol synthase1 (tgs1) deletion mutant, with impaired ability to accumulate TG, exhibited a lesser degree of antibiotic tolerance and complementation restored antibiotic tolerance. Transcriptome analysis with microarray revealed the achievement of dormant state showing repression of energy generation, transcription and translation machineries and induction of stress-responsive genes. We adapted this model for drug screening using the Alamar Blue dye to quantify the antibiotic tolerant dormant cells. CONCLUSIONS/SIGNIFICANCE: The new in vitro multiple stress dormancy model efficiently generates Mtb cells meeting all criteria of dormancy, and this method is adaptable to high-throughput screening for drugs that can kill dormant Mtb. A critical link between storage-lipid accumulation and development of phenotypic drug-resistance in Mtb was established. Storage lipid biosynthetic genes may be appropriate targets for novel drugs that can kill latent Mtb.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184 · cited 1×
“Intensity-dependent print-tip MAD normalization, Quantile normalization, and hierarchical clustering [63] were performed with R as described before [64].”
MethodIn silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Controlling the false discovery rate in behavior genetics research
Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N., & Golani, I. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00297-2 · Cited by 4,146
Collins, L., & Franzblau, S. G. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1004 · Cited by 1,599 · cited 1×
“Adaptation of multiple-stress model for drug screening In order to assess whether our in vitro dormancy model can be used for drug screening, we used a modification of the Alamar Blue dye method [40–42] that can allow quick screening for viability of mycobacterial cells following antibiotic treatment [43].”
MethodTranscriptional Adaptation of Mycobacterium tuberculosis within Macrophages
Schnappinger, D., Ehrt, S., Voskuil, M. I., Liu, Y., Mangan, J. A., Monahan, I. M., Dolganov, G., Efron, B., Butcher, P. D., Nathan, C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030846 · Cited by 1,420 · cited 1×
“Rv0221 and Rv1425 were reported to be up-regulated in intraphagosomal lesions [58].”
BackgroundBetts, J. C., Lukey, P. T., Robb, L. C., McAdam, R. A., & Duncan, K. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02779.x · Cited by 1,395 · cited 10×
“In the nutrient starvation model about 60% tolerance against Rif (at 1 mg/ml) was reported after 42 days under the stress [21], whereas, in our model we observed about 50% survival at the same concentration of Rif within 18 days (data not shown).”
BackgroundMethodResultInfluentialChemistry and Biochemistry of Natural Waxes
Arndt, K. A., & Benson, A. A. (1977) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12497597 · Cited by 1,199
Wayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141 · cited 7×
“However, development of drug tolerance has been assessed only in few in vitro dormancy models [21,24].”
BackgroundMethodInfluentialInhibition of Respiration by Nitric Oxide Induces a Mycobacterium tuberculosis Dormancy Program
Voskuil, M. I., Schnappinger, D., Visconti, K. C., Harrell, M. I., Dolganov, G. M., Sherman, D. R., & Schoolnik, G. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030205 · Cited by 966
Cited by
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
Daniel, J., Maamar, H., Deb, C., Sirakova, T. D., & Kolattukudy, P. E. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002093 · Cited by 608
Self-citationCaseation of human tuberculosis granulomas correlates with elevated host lipid metabolism
Kim, M., Wainwright, H. C., Locketz, M., Bekker, L., Walther, G. B., Dittrich, C., Visser, A., Wang, W., Hsu, F., Wiehart, U., et al. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000079 · Cited by 489
The dynamic roles of intracellular lipid droplets: from archaea to mammals
Murphy, D. J. (2012) · Protoplasma · doi:10.1007/s00709-011-0329-7 · Cited by 397
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
Lenaerts, A., Barry, C. E., & Dartois, V. (2015) · Immunological Reviews · doi:10.1111/imr.12252 · Cited by 362
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
Zumla, A. I., Gillespie, S. H., Hoelscher, M., Philips, P. P. J., Cole, S. T., Abubakar, I., McHugh, T. D., Schito, M., Maeurer, M., & Nunn, A. J. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70328-1 · Cited by 342
Metabolic Regulation of Mycobacterial Growth and Antibiotic Sensitivity
Baek, S.-H., Li, A. H., & Sassetti, C. M. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001065 · Cited by 324
“The propensity for mycobacteria to accumulate TAG in response to stress has been described previously [20,31], but the physiological role of this response has remained unclear.”
BackgroundCortes, T., Schubert, O. T., Rose, G., Arnvig, K. B., Comas, I., Aebersold, R., & Young, D. B. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.031 · Cited by 310
“…5, 1121–1131, November 27, 2013 ª2013 The Authors 1121 strains in well-characterized experimental models involving uptake of bacteria by macrophages and withdrawal of oxygen or other nutrients (Rustad et al., 2008; Rohde et al., 2012; Betts et al., 2002; Stewart et al., 2002; Deb et al., 2009).”
Resuscitation-promoting Factors Reveal an Occult Population of Tubercle Bacilli in Sputum
Mukamolova, G. V., Turapov, O., Malkin, J., Woltmann, G., & Barer, M. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0661oc · Cited by 280
Targeting Persisters for Tuberculosis Control
Zhang, Y., Yew, W. W., & Barer, M. R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06288-11 · Cited by 271
Andrabi, S. A., Kang, H. C., Haince, J.-F., Lee, Y.-I., Zhang, J., Chi, Z., West, A. B., Koehler, R. C., Poirier, G. G., Dawson, T. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2387 · Cited by 216
“We obtained similar results using Alamar Blue reduction to assess cell viabilit”
Human Granuloma In Vitro Model, for TB Dormancy and Resuscitation
Kapoor, N., Pawar, S., Sirakova, T. D., Deb, C., Warren, W. L., & Kolattukudy, P. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053657 · Cited by 209
Self-citationLiu, Y., Tan, S., Huang, L., Abramovitch, R. B., Rohde, K. H., Zimmerman, M. D., Chen, C., Dartois, V., VanderVen, B. C., & Russell, D. G. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151248 · Cited by 209
Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence
Zheng, H., Colvin, C. J., Johnson, B. K., Kirchhoff, P. D., Wilson, M., Jorgensen-Muga, K., Larsen, S. D., & Abramovitch, R. B. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2259 · Cited by 169
Bacon, J., Alderwick, L. J., Allnutt, J. A., Gabasova, E., Watson, R., Hatch, K. A., Clark, S. O., Jeeves, R. E., Marriott, A., Rayner, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087329 · Cited by 74
“Previously reported dormancy models have shown an apparent increase in TAG, but these have been under alternative growth conditions, which serve to highlight the contributions made by different microenvironments with respect to nonreplicating persistence [53] [54] [55] [56].”
BackgroundSawyer, E. B., Phelan, J. E., Clark, T. G., & Cortes, T. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108695 · Cited by 25
“…to stress have been extensively analyzed by transcriptional profiling in well-defined experimental models (Stewart et al., 2002; Betts et al., 2002; Deb et al., 2009; Rohde et al., 2012; Galagan et al., 2013; Rustad et al., 2014; Namouchi et al., 2016; Aguilar-Ayala et al., 2017; Cell Reports 34,…”
Method
Metadata
- Authors
- Deb, C., Lee, C.-M., Dubey, V. S., Daniel, J., Abomoelak, B., Sirakova, T. D., Pawar, S., Rogers, L., & Kolattukudy, P. E.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-06-29
- Volume
- 4
- Issue
- 6
- Pages
- e6077
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2078663039
- Cited by
- 440
- References
- 62
- FWCI
- 12.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.